Thousands of women at risk of cervical cancer as smear test uptake in England has fallen to a record low
The immunotherapy drug pembrolizumab is expected to help around 400 patients whose disease hasn’t responded to other treatments
The latest cervical screening coverage statistics from Scotland and England show that one in three women are not taking up their cervical screening invitation. These figures are far lower than the...
The HPV vaccine has been shown to dramatically reduce cervical cancer rates by almost 90% in women in their 20s who were offered it at age 12-13
BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.
Clinical expertise
Peer-reviewed research
Best practice guidance
CPD support
